Skip to main content
Imaging in PMR
Despite the fact that polymyalgia rheumatica is the most prevalent inflammatory rheumatic disease in those over 65 years of age, progress in its diagnosis, monitoring and management have failed to garner momentum in decades past. However, ACR22 has fostered significant promise for its future.
ACR 2022 Appraisal, Praise & Critique (11.18.2022)

It was great to be back at an ACR annual meeting, this one in Philadelphia - Philly was great. A walking town, rich in culture, history and good places to meet and mingle. 

I loved the city, but not the convention center (not easy to navigate). 

The meeting itself was very good. Be sure to logon and listen to the Year in Review (Drs. Langford and Varga) and the Keynote address from Dr. Abraham Verghese (Stanford) - both are well worth your time.

Repetitive Testing of Anti-dsDNA Antibodies May Predict Flares in SLE Dr. Sheila Reyes ( @RHEUMarampa ) summarizes ab

Social Author Name
Dr. John Cush
Tweet Content
Repetitive Testing of Anti-dsDNA Antibodies May Predict Flares in SLE Dr. Sheila Reyes ( @RHEUMarampa ) summarizes abstract #0327 presented during the poster session at #ACR22. https://t.co/kSFfyRIQXZ https://t.co/bVTE9VsFmC

2022 ACR/EULAR Classification Criteria for GCA Dr. Michael Putman discusses interesting take-home messages from the Va

Social Author Name
Dr. John Cush
Tweet Content
2022 ACR/EULAR Classification Criteria for GCA Dr. Michael Putman discusses interesting take-home messages from the Vasculitis Investigators Meeting at ACR22 Convergence regarding the 2022 ACR/EULAR Classification Criteria for GCA. https://t.co/w7NE2Wpm95 https://t.co/vB94wS7ONF
Subscribe to
×